Search

everythinglearnresearchcommunity

for

Search:↓

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

CD4+ skin cells may be precursors to basal cell carcinoma.

Immunotherapies for non-small cell lung cancer show promise in improving treatment and reducing side effects.

T cells with memory features grow in number and gather around hair follicles when there are not enough immune cells.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

FTY720 helps transplanted fat survive better by reducing immune rejection and improving blood vessel growth.

ETS2 is crucial in squamous cell carcinoma development and could be a therapeutic target.

A new TP63 mutation was found in a baby with EEC syndrome, showing the need for TREC testing to check for immune issues.

Topical IKKα inhibitors may help prevent CCS tumours.

Cutaneous epitheliotropic lymphoma in dogs is often misdiagnosed but can be treated with chemotherapy and alternative therapies.

Treat limited stage small cell lung cancer with chemotherapy and radiation, and consider preventive brain radiation for better survival chances.

Skin's Regulatory T cells are crucial for maintaining skin health and could be targeted to treat immune-related skin diseases and cancer.

CD18-deficient mice developed psoriasis-like skin disease, useful for studying inflammatory skin disorders.

Cathepsin L deficiency causes large, abnormal cell structures and health issues in mice.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

Treg cells help repair and regenerate tissues by interacting with local cells.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Mesenchymal stem cells from laser-assisted liposuction are as effective and safe as those from conventional liposuction for cell therapy.

Regulatory T cells are essential for normal and improved wound healing in mice.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

The Lexington LaserComb helped regrow hair in mice with a condition similar to human hair loss.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Topical latanoprost doesn't effectively regrow hair in severe eyebrow alopecia areata cases.

Pimecrolimus cream is not effective for treating alopecia areata.